A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1777, Issue 10, 2008, Pages 1289-1300

  Atlante, A ^a   Amadoro, G ^a   Bobba, A ^a   de Bari, L ^a   Corsetti, V ^a,b   Pappalardo, G ^a   Marra, E ^a   Calissano, P ^a,b   Passarella, S ^c  

^a CNR   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

ATP synthesis; Cerebellar granule cells; Mitochondria; Neurotoxicity; Oxidative phosphorylation; Tau fragment

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CYTOCHROME C OXIDASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TAU PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CEREBELLUM CORTEX; CONTROLLED STUDY; ELECTRON TRANSPORT; ENZYME ACTIVITY; GRANULE CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ELECTRON TRANSPORT COMPLEX IV; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL ADP, ATP TRANSLOCASES; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; TAU PROTEINS;

ADENOVIRIDAE;

EID: 52949119162     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2008.07.004     Document Type: Article

References (64)

1. Amadoro G., Serafino A.L., Barbato C., Ciotti M.T., Sacco A., Calissano P., and Canu N. Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons. Cell Death Differ. 11 (2004) 217-230
2. Rohn T.T., Rissman R.A., Davis M.C., Kim Y.E., Cotman C.W., and Head E. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol. Dis. 11 (2002) 341-354
3. Fasulo L., Ugolini G., Visentin M., Bradbury A., Brancolini C., Verzillo V., Novak M., and Cattaneo A. The neuronal microtubule-associated protein tau is substrate of caspase-3 and an effector of apoptosis. J. Neurochem. 75 (2000) 624-633
4. Chung C.W., Song Y.H., Kim I.K., Yoon W.J., Ryu B.R., Jo D.G., Woo H.N., Kwon Y.K., Kim H.H., Gwag B.J., Mook-Jung I.H., and Jung Y.K. Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol. Dis. 8 (2001) 162-172
5. Avila J., Lucas J.J., Perez M., and Hernandez F. Role of tau protein in both physiological and pathological conditions. Physiol. Rev. 84 (2004) 361-384 (Review)
6. Amadoro G., Ciotti M.T., Costanzi M., Cestari V., Calissano P., and Canu N. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2892-2897
7. Levi G., Aloisi F., Ciotti M.T., and Gallo V. Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures. Brain Res. 290 (1984) 77-86
8. Almeida A., and Medina J.M. A rapid method for the isolation of metabolically mitochondria form rat neurons and astrocytes in primary culture. Brain Res. Brain Res. Protoc. 3 (1998) 209-214
9. Waddel W.J., and Hill C. A simple ultraviolet spectrophotometer method for the determination of protein. J. Lab. Clin. Med. 48 (1956) 311-314
10. Atlante A., Bobba A., de Bari L., Fontana F., Calissano P., Marra E., and Passarella S. Caspase-dependent alteration of the ADP/ATP translocator triggers the mitochondrial permeability transition which is not required for the low-potassium-dependent apoptosis of cerebellar granule cells. J. Neurochem. 97 (2006) 1166-1181
11. Trumbeckaite S., Opalka J.R., Neuhof C., Zierz S., and Gellerich F.N. Different sensitivity of rabbit heart and skeletal muscle to endotoxin-induced impairment of mitochondrial function. Eur. J. Biochem. 268 (2001) 1422-1429
12. Wharton D.C., and Tzagaloff A. Cytochrome c oxidase from beef heart mitochondria. Methods Enzymol. 10 (1967) 245-253
13. Atlante A., de Bari L., Bobba A., Marra E., Calissano P., and Passarella S. Cytochrome c, released from cerebellar granule cells undergoing apoptosis or excytotoxic death, can generate protonmotive force and drive ATP synthesis in isolated mitochondria. J. Neurochem. 86 (2003) 591-604
14. Atlante A., Passarella S., Quagliariello E., Moreno G., and Salet C. Haematoporphyrin derivative (Photofrin II) photosensitization of isolated mitochondria: inhibition of ADP/ATP translocator. J. Photochem. Photobiol. B 4 (1989) 35-46
15. Canu N., Dus L., Barbato C., Ciotti M.T., Brancolini C., Rinaldi A.M., Novak M., Cattaneo A., Bradbury A., and Calissano P. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18 (1998) 7061-7074
16. Rohn T.T., Head E., Su J.H., Anderson A.J., Bahr B.A., Cotman C.W., and Cribbs D.H. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am. J. Pathol. 158 (2001) 189-198
17. Ugolini G., Cattaneo A., and Novak M. Co-localization of truncated tau and DNA fragmentation in Alzheimer's diseases neurons. Neuroreport 8 (1997) 3709-3712
18. Gastard M.C., Troncoso J.C., and Koliatsos V.E. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease. Ann. Neurol. 54 (2003) 393-398
19. Saito K., Elce J.S., Hamos J.E., and Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 26-28
20. Veeranna, Kaji T., Boland B., Odrljin T., Mohan P., Basavarajappa B.S., Peterhoff C., Cataldo A., Rudnicki A., Amin N., Li B.S., Pant H.C., Hungund B.L., Arancio O., and Nixon R.A. Calpain mediates calcium-induced activation of the ERK1/2, MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am. J. Pathol. 165 (2004) 795-805
21. Cardoso S.M., Santana I., Swerdlow R.H., and Oliveira C.R. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J. Neurochem. 89 (2004) 1417-1426
22. Mancuso M., Coppedè F., Murri L., and Siciliano G. Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?. Antioxid. Redox Signal. 9 (2007) 1631-1646
23. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J., Wilson J.M., DiStefano L.M., and Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59 (1992) 776-779
24. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thal L.J., Beal M.F., Howell N., and Jr Parker W.D. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4526-4531
25. Beal M.F. Oxidative metabolism. Ann. N. Y. Acad. Sci. 924 (2000) 164-169
26. Mutisya E.M., Bowling A.C., and Beal M.F. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63 (1994) 2179-2184
27. Sims N.R., Finegan J.M., Blass J.P., Bowen D.M., and Neary D. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res. 436 (1987) 30-38
28. Reynolds M.R., Berry R.W., and Binder L.I. Site-specific nitration differentially influences tau assembly in vitro. Biochemistry 44 (2005) 13997-14009
29. Gamblin T.C., Berry R.W., and Binder L.I. Modeling tau polymerization in vitro. A review and synthesis. Biochemistry 42 (2003) 15009-15017
30. Yang L.S., and Ksiezak-Reding H. Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur. J. Biochem. 233 (1995) 9-17
31. Cente M., Filipcik P., Pevalova M., and Novak M. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. Eur. J. Neurosci. 24 (2006) 1085-1090
32. Chothia C., and Janin J. Principles of protein-protein recognition. Nature 256 (1975) 705-708
33. Tsai C.J., Lin S.L., Wolfson H.J., and Nussinov R. Studies of protein-protein interfaces: a statistical analysis of the hydrophobic effect. Protein Sci. 6 (1997) 53-64
34. Janin J., and Chothia C. The structure of protein-protein recognition sites. J. Biol. Chem. 265 (1990) 16027-16030
35. Korn A.P., and Burnett R.M. Distribution and complementarity of hydropathy in multisubunit proteins. Proteins 9 (1991) 37-55
36. Vakser I.A., and Aflalo C. Hydrophobic docking: a proposed enhancement to molecular recognition techniques. Proteins 20 (1994) 320-329
37. Young L., Jernigan R.L., and Covell D.G. A role for surface hydrophobicity in protein-protein recognition. Protein Sci. 3 (1994) 717-729
38. Jones S., and Thornton J.M. Protein-protein interaction: a review of protein dimer structures. Prog. Biophys. Mol. Biol. 63 (1995) 131-165
39. Jones S., and Thornton J.M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13-20
40. Larsen T.A., Olson A.J., and Goodsell D.S. Morphology of protein-protein interfaces. Structure 6 (1998) 421-427
41. Lo Conte L., Chothia C., and Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285 (1999) 2177-2198
42. Glaser F., Steinberg D.M., Vakser A., and Ben-Tal N. Residue frequencies and pairing preferences at protein-protein interfaces. Proteins 43 (2001) 89-102
43. Chakrabarti P., and Janin J. Dissecting protein-protein recognition sites. Proteins 47 (2002) 334-343
44. Klingenberg M. Molecular aspects of the adenine nucleotide carrier from mitochondria. Arch. Biochem. Biophys. 270 (1989) 1-14
45. Majima E., Yamaguchi N., Chuman H., Shinohara Y., Ishida M., Goto S., and Terada H. Binding of the fluorescein derivative eosin Y to the mitochondrial ADP/ATP carrier: characterization of the adenine nucleotide binding site. Biochemistry 37 (1998) 424-432
46. Kini R.M., and Evans H.J. Prediction of potential protein-protein interaction sites from amino acid sequence identification of a fibrin polymerization site. FEBS Lett. 385 (1996) 81-86
47. Stamer K., Vogel R., Thies E., Mandelkow E., and Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhance oxidative stress. J. Cell Biol. 156 (2002) 1051-1063
48. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B., and Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implication for Alzheimer's disease. J. Cell Biol. 143 (1998) 777-794
49. Santagata D.D., Fulga T., Duttaroy A., and Feany M.B. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Inv. 117 (2007) 236-245
50. Thies E., and Mandelkow E.M. Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J. Neurosci. 27 (2007) 2896-2907
51. David D.C., Hauptmann S., Scherping I., Schuessel K., Keil U., Rizzu P., Ravid R., Drose S., Brandt U., Muller W.E., Eckert A., and Gotz J. Proteomic and functional analyses reveal a mitochondrial dysfunction in P3201L tau transgenic mice. J. Biol. Chem. 280 (2005) 23802-23814
52. Zilka N., Filipcik P., Koson P., Fialova L., Skrabana R., Zilkova M., Rolkova G., Kontsekova E., and Novak M. Truncated tau form sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett. 580 (2006) 3582-3588
53. Liu R., Yuan B., Emadi S., Zameer A., Schulz P., McAllister C., Lyubchenko Y., Goud G., and Sierks M.R. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity. Biochemistry 43 (2004) 6959-6967
54. Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E.B.V., Rotilio G., Selverstone Valentine J., and Carrì M.T. familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc. Natl. Acad. Sci. 103 (2006) 13860-13865
55. Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., and Greenamyre J.T. Early mitochondrial calcium defects in Hungtington's disease are direct effect of polyglutamines. N. Neurosci. 5 (2002) 731-736
56. Panov A.V., Burke J.R., Strittmatter W.J., and Greenamyre J.T. In vitro effects pf polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Hungtington's disease. Arch. Biochem. Biophys. 410 (2003) 1-6
57. Seong I.S., Ivanova E., Lee J.M., Choo Y.S., Fossale E., Anderson M.A., Gusella J.F., Laramie J.M., Myers R.H., Lesort M., and MacDonald M.E. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum. Mol. Genet. 14 (2005) 2871-2880
58. Rendon A., Jung D., and Jancsik V. Interaction of microtubules and microtubule-associated proteins (MAPs) with rat brain mitochondria. Biochem. J. 269 (1990) 555-556
59. Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., Trinchese F., Liu S., Gunn-Moore F., Lue L.F., Walker D.G., Kuppusamy P., Zewier Z.L., Arancio O., Stern D., Yan S.S., and Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304 (2004) 448-452
60. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79 (1999) 1431-1568 (Review)
61. Pettmann B., and Henderson C.E. Neuronal cell death. Neuron 20 (1998) 633-647 (Review)
62. Rothman S.M., and Olney J.W. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 18 (1995) 57-58 (Review)
63. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
64. Choi D.W. Glutamate receptors and the induction of excitotoxic neuronal death. Prog. Brain Res. 100 (1994) 47-51